FDA Adverse Event Injury Summary report: N

SPRINT QUATTRO SECURE S

MDR report key: 3160366 · Received June 10, 2013

Report

Report Number
2649622-2013-08017
Event Type
Injury
Date Received
June 10, 2013
Report Date
March 26, 2013
Manufacturer
MPRI
Product Code
LWS
PMA / PMN Number
P920015
Removal / Correction Number
Z-0474-2011
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
MA, US
Reporter Occupation
PHYSICIAN

Narratives

Additional Manufacturer Narrative · 1

PRODUCT EVENT SUMMARY: THE FULL LEAD WAS RETURNED, ANALYZED, AND NO ANOMALIES WERE FOUND. THIS DEVICE WAS INCLUDED IN THAT FIELD ACTION, BUT RETURNED PRODUCT TESTING FOUND THE DEVICE DID NOT PERFORM AS DESCRIBED IN THE FIELD ACTION.

Additional Manufacturer Narrative · 1

THE INFORMATION SUBMITTED REFLECTS ALL RELEVANT DATA RECEIVED. IF ADDITIONAL RELEVANT INFORMATION IS RECEIVED, A SUPPLEMENTAL REPORT WILL BE SUBMITTED. 5076-52 IMPLANTABLE PACING LEAD 2007 (B)(6); (B)(4) IMPLANTABLE CARDIOVERTER DEFIBRILLATOR 2010 (B)(6). (B)(4).

Additional Manufacturer Narrative · 1

IF INFORMATION IS PROVIDED IN THE FUTURE, A SUPPLEMENTAL REPORT WILL BE ISSUED.

Description of Event or Problem · 1

IT WAS REPORTED THAT THE PATIENT DEVELOPED VEGETATIVE ENDOCARDITIS. THE IMPLANTABLE CARDIOVERTER DEFIBRILLATOR (ICD) AND LEAD WERE EXPLANTED AND NO REPLACED SECONDARY TO SEPSIS. THE PATIENT IS ENROLLED IN THE SYSTEM LONGEVITY STUDY (SLS). NO FURTHER PATIENT COMPLICATIONS HAVE BEEN REPORTED AS A RESULT OF THIS EVENT.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
259896 SPRINT QUATTRO SECURE S DEFIBRILLATOR, AUTOMATIC IMPLANTABLE CARDIOVERTER LWS MPRI 693558

Patients

Seq Age Sex Outcome Treatment
1 00047 YR Hospitalization| R